332 related articles for article (PubMed ID: 19914443)
1. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
; Borowitz D; Parad RB; Sharp JK; Sabadosa KA; Robinson KA; Rock MJ; Farrell PM; Sontag MK; Rosenfeld M; Davis SD; Marshall BC; Accurso FJ
J Pediatr; 2009 Dec; 155(6 Suppl):S106-16. PubMed ID: 19914443
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB; Comeau AM
J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
[TBL] [Abstract][Full Text] [Related]
8. CF versus CRMS: diagnostic challenges in cystic fibrosis.
Temme R; Roggenbuck J; McNamara J
Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
[TBL] [Abstract][Full Text] [Related]
9. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
[TBL] [Abstract][Full Text] [Related]
10. A survey of newborn screening for cystic fibrosis in Europe.
Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
[TBL] [Abstract][Full Text] [Related]
11. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
12. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic challenges in CFTR-related metabolic syndrome: Where the guidelines fall short.
Kallam EF; Kasi AS; Barr E; Linnemann RW; Guglani L
Paediatr Respir Rev; 2024 Mar; 49():28-33. PubMed ID: 37659865
[TBL] [Abstract][Full Text] [Related]
14. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
15. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
16. The diagnosis of cystic fibrosis.
De Boeck K; Vermeulen F; Dupont L
Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
[TBL] [Abstract][Full Text] [Related]
17. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
Terlizzi V; Claut L; Colombo C; Tosco A; Castaldo A; Fabrizzi B; Lucarelli M; Cimino G; Carducci C; Dolce D; Biffi A; Bonomi P; Timpano S; Padoan R
Pediatr Pulmonol; 2021 Dec; 56(12):3785-3791. PubMed ID: 34549893
[TBL] [Abstract][Full Text] [Related]
19. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
[TBL] [Abstract][Full Text] [Related]
20. Detection of disease-causing CFTR variants in state newborn screening programs.
McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
